New York, NY -- (SBWIRE) -- 02/01/2013 -- Cortex Pharmaceuticals Inc. (OTCPINK: CORX) opened at $0.04 and oscillated in the range of $0.042 and $0.043 in the latest trading session. It is at $0.042 and the stock shows bullish trend. its first resistance level is at $0.05. Upon breaching this level, the stock may touch $0.06. On the downside, it may slip to $0.03. Cortex Pharmaceuticals has traded 49k shares so far.
The company is based out of California and it was formed in 1987. Cortex Pharmaceuticals develops and markets therapies for psychiatric and neurological disorders. The company is currently developing AMPAKINE compounds for treating depression and mild cognitive impairment.
Find out where CORX could be headed by getting the free full report here: http://www.wallstreetreport.net/market-scan/?symbol=CORX
Rite Aid Corporation (NYSE: RAD) traded in the range of $1.68 and $1.76 during its latest trading session. The stock had opened at $1.72 and is currently at $1.70, up 6.25 percent from its previous close of $1.60. Rite Aid Corporation recorded the volume of 15.767 million shares, significantly higher than its average daily trading volume of 11.428 million shares, thus showing bullish trend. It is also trading above its 6 days EMA of $1.62 and 20 days EMA of $1.51.
Rite Aid Corporation announced that it has started the process of debt refinancing for its outstanding loans.
Could letting investors know the company is starting to pay its loan help RAD maintain its momentum in the upcoming trading sessions? Find out here:
WallStreetReport.net issues momentum alerts on stocks that can provide gains to day traders. WallStreetReport.net provides members with timely information and exclusive alerts on cheap and under-valued stocks in the United States with the potential to deliver gains of 100% - 200% or more. WallStreetReport.net monitors and scans the markets for stock related signals as well as any external factors that might bring trading opportunities.Through a vast network of IR professionals WallStreetReport.net is often in the know of several large investor awareness campaigns being deployed.
Timing is everything when trading Penny Stocks. Gain an Edge by joining the WallStreetReport.net newsletter and receiving alerts from a Pro-Active team of researchers. Wall Street Report believes traders should have a chance at successfully trading Penny Stocks and invites traders and investors to be part of the Free VIP membership.
Simply sign up for free and start receiving exclusive alerts.
Subscribe Here: http://www.WallStreetReport.net
Disclosure: WallStreetReport.net is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Please visit WallStreetreport.Net website, for complete risks and disclosures.
BlueLys, its employees, officers, directors, shareholders and affiliates, hold no positions in the above-mentioned stocks.
WALL STREET REPORT